Archives
-
Foretinib: Five Questions About Cancer Evidence
2026-10-04
A source-grounded overview of Foretinib (GSK1363089), examining its multikinase rationale, how to interpret reported growth and motility effects, the strength of available evidence, and the limits of translating cell and xenograft findings into broader cancer conclusions.
-
One-step TUNEL FITC: Reading Apoptosis Evidence
2026-10-03
The One-step TUNEL FITC Apoptosis Detection Kit provides a fluorescence-based readout of DNA fragmentation, but its strongest value emerges when interpreted alongside pathway-specific evidence. This article connects TUNEL signal interpretation with recent findings on MST1/2-dependent macrophage death and defines the assay’s evidentiary boundaries.
-
CFDA SE Cell Tracer Kit: Protocol Guide
2026-10-02
The CFDA SE Cell Tracer Kit enables persistent fluorescent labeling for cell lineage tracing, proliferation monitoring, and live-cell distribution studies. It is intended for durable covalent marking over several days, not reversible or strictly short-term labeling, and should be optimized for each cell type and detection platform.
-
ARL4C Links Synoviocyte Growth to RA Inflammation
2026-10-01
The reference study integrates single-cell and bulk transcriptomics with cellular perturbation, co-culture, and collagen-induced arthritis experiments to position ARL4C as a regulator of rheumatoid arthritis fibroblast-like synoviocyte behavior and macrophage polarization. Its findings connect ARL4C with PI3K/AKT and MAPK signaling, while also illustrating how direct S-phase measurements can complement mechanistic studies of synoviocyte proliferation.
-
Eldecalcitol, Endothelial Ferroptosis, and T2DOP
2026-10-01
The reference study identifies endothelial ferroptosis as a mechanistic link between the diabetic microenvironment and impaired bone vascular–osteogenic coupling, and shows that eldecalcitol acts through the SOCE/O-GlcNAcylation axis. Its combined cell, mouse, functional, and pharmacological-intervention design provides a framework for studying vascular contributions to type 2 diabetic osteoporosis and for interpreting lipid oxidation readouts.
-
CFDA SE Cell Tracer Kit: Practical Guide
2026-09-30
The CFDA SE Cell Tracer Kit provides stable fluorescent labeling for multi-day cell tracking, cell proliferation studies, and lineage-tracing workflows. It is intended for covalent, persistent labeling rather than reversible staining or short-term assays, and loading conditions should be optimized for each cell type.
-
From Protein Preservation to Better Cell-Death Decisions
2026-09-30
A translational framework for using Annexin V-FITC/7-AAD phenotyping to connect processing conditions, preserved bioactivity, and defensible cell-death conclusions.
-
CCK-8: WST-8 Cell Viability Assay Guide
2026-09-29
Cell Counting Kit-8 (CCK-8) uses WST-8 reduction to quantify viable-cell-associated metabolic activity without a formazan solubilization step. It is useful for cell proliferation assay, cytotoxicity assay, and cell viability measurement when signal linearity and metabolic confounding are experimentally validated.
-
Osthole–TGM2 Axis in RA and RA-ILD
2026-09-29
The reference study identifies an osthole-sensitive TGM2/Myc/WTAP feedback circuit that links N6-methyladenosine regulation to rheumatoid arthritis and associated interstitial lung disease. Its integrated cellular, molecular, animal, and bioinformatics evidence supports TGM2 as a potential therapeutic target while showing how osthole may complement methotrexate and limit both synovial and pulmonary disease features.
-
PX-478 in Prenatal Hypoxia-Induced ASD-Like Behavior
2026-09-28
A 2024 rat study tested whether pharmacological inhibition of HIF-1α could modify autism-like outcomes caused by prenatal hypoxia. PX-478 improved behavioral and hippocampal measures, but treatment timing affected body weight and liver-enzyme findings, emphasizing both mechanistic interest and the need for cautious translational interpretation.
-
7-AAD Cell Viability Assay Kit: Reading Cell Death
2026-09-28
The 7-AAD Cell Viability Assay Kit provides a membrane-integrity readout that can sharpen interpretation of CD38 CAR-T experiments. This article connects the probe’s strengths and limitations to structural insights into CAR binder affinity, helping researchers distinguish observed cell death from the mechanisms that may cause it.
-
Cell Counting Kit-8 for Parkinson’s Disease Models
2026-09-27
Use CCK-8 to quantify viable-cell signals while testing how astrocyte BMP signaling and inflammatory conditions affect dopaminergic neuron cultures. This practical guide pairs a flexible WST-8 workflow with controls that help distinguish cell loss from shifts in cellular metabolism.
-
Mapping Plastid DNA Breaks in Arabidopsis
2026-09-26
The Arabidopsis study uses DEtail-seq to chart plastid DNA break patterns across development and environmental conditions, revealing age-related damage, rDNA-region hotspots, and vulnerabilities in DNA maintenance mutants. Its findings establish a genome-wide framework for studying plastid DNA integrity, while highlighting that ROS measurements are complementary to—not a substitute for—direct break profiling.
-
2-NBDG Workflow for Cellular Glucose Uptake
2026-09-25
Turn transporter-dependent glucose entry into a fluorescent, single-cell or population-level readout with 2-NBDG. This workflow connects uptake measurements to a published arsenic-induced hepatocyte model while distinguishing probe accumulation from downstream glycolytic activity.
-
Acridine Orange hydrochloride: Practical Staining Guide
2026-09-25
Acridine Orange hydrochloride provides green- and red-emitting nucleic acid staining that can support cell cycle analysis, apoptosis detection workflows, and flow cytofluorometric nucleic acid staining. Use it in validated, nucleic-acid-focused assays with freshly prepared dye; do not treat fluorescence alone as proof of apoptosis, RNA identity, or absolute nucleic acid content.